Moderna’s Chantal Friebertshäuser on vaccine confidence - EMJ

Moderna’s Chantal Friebertshäuser on improving vaccine confidence

EMJ GOLD
Series 8: episode 1

The EMJ GOLD podcast is back! In the first episode of season 8, Jade sits down with Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna, to discuss how Europe can combat the recent erosion of trust in vaccines.

Together, the two explore the role of governments in addressing vaccine hesitancy, improving vaccine education amongst various groups, how a culture of collaboration can improve the current vaccine landscape and much more.

A little more on GOLD’s guest…

Chantal Friebertshäuser is Senior Vice President and General Manager, Commercial for the EMEAC region at Moderna, overseeing Europe, the Middle East, Australia and Canada. She has been with the company since January 2023 and is responsible for spearheading commercial initiatives across these diverse markets.

She holds an impressive 25-year tenure in the global pharmaceutical industry, having served as Senior Vice President and Managing Director at MSD, acted as Global Commercial Lead for the company’s HPV vaccine franchise, and spent ten years in various roles at Eli Lilly.

Chantal holds a Master of Arts in International Business from the School of Business ESC in Rennes, France, and is currently based in Switzerland.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given